Filing Details

Accession Number:
0001231977-11-000067
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-07-27 17:57:52
Reporting Period:
2011-07-25
Filing Date:
2011-07-27
Accepted Time:
2011-07-27 17:57:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899866 Alexion Pharmaceuticals Inc ALXN Pharmaceutical Preparations (2834) 133648318
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1283700 Larry Mathis 352 Knotter Dr
C/O Alexion Pharmaceuticals Inc
Cheshire CT 06410
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Per Share Acquisiton 2011-07-25 24,000 $5.73 37,450 No 4 M Direct
Common Stock, Par Value $.0001 Per Share Disposition 2011-07-25 24,000 $58.62 13,450 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $.0001 Per Share Option to Purchase Common Stock Disposition 2011-07-25 24,000 $0.00 24,000 $5.73
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
24,000 2004-06-15 2014-03-15 No 4 M Direct
Footnotes
  1. Reporting person's ownership reflects the 2:1 common stock split effected by Alexion in the form of a dividend on May 20, 2011.
  2. This transaction was executed in multiple trades through a broker-dealer at prices ranging from $58.31 - $58.86. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.